Deflated, frustrated and upset.
That’s how Lyn Cleaver describes her emotions, after her son Jeremy Bester was officially rejected from the Controlled Access Scheme (CAS) for medicinal cannabis in Tasmania.
Jeremy has refractory epilepsy, and has trialled over 16 drugs since he was diagnosed at five years old. Many of the drugs have had concerning side affects on Jeremy.
Lyn joins Fairsy, who is filling in for Brian Carlton this morning, to talk about the rejection, and what the next step is for Jeremy.